IsoPSA Blood Test Shows Promising Results for Early Prostate Cancer Diagnosis

IsoPSA Blood Test Shows Promising Results for Early Prostate Cancer Diagnosis
IsoPSA, a blood test developed by Cleveland Diagnostics that detects cancer-derived PSA, is more accurate in diagnosing prostate cancer than a conventional PSA test and reduces the need for biopsies by nearly half, according to the results of a U.S.-based study. The findings were published in the journal European Urology under the title, “The Single-parameter, Structure-based IsoPSA

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *